Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 11, 2014, Pages 4158-4166

  Monticone, Silvia ^a   Satoh, Fumitoshi ^c   Viola, Andrea ^a   Fischer, Evelyn ^d   Vonend, Oliver ^e   Bernini, Giampaolo ^f   Lucatello, Barbara ^b   Quinkler, Marcus ^g   Ronconi, Vanessa ^h   Morimoto, Ryo ^c   Kudo, Masataka ^c   Degenhart, Christoph ^f   Gao, Xing ^e   Carrara, Davide ^d   Willenberg, Holger S ^e   Rossato, Denis ^a   Mengozzi, Giulio ⁱ   Riester, Anna ^d   Paci, Enrico ^h   Iwakura, Yoshitsugu ^c   Burrello, Jacopo ^a   Maccario, Mauro ^b   Giacchetti, Gilberta ^h   Veglio, Franco ^a   Ito, Sadayoshi ^c   Reincke, Martin ^d   Mulatero, Paolo ^a   more..

^a UNIVERSITY OF TURIN   (Italy)

^b Division of Endocrinology   (Italy)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY OF PISA   (Italy)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

ⁱ CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CORTICOTROPIN;

ADRENAL SUPPRESSION; ADRENAL VEIN SAMPLING; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENDOCRINE SYSTEM EXAMINATION; FEMALE; GERMANY; HUMAN; ITALY; JAPAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREDICTION; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; ADRENAL GLAND; BLOOD; HYPERALDOSTERONISM; PHYSIOLOGY; VASCULARIZATION;

ADRENAL GLANDS; ADRENALECTOMY; ALDOSTERONE; BLOOD PRESSURE; FEMALE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84910002109     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2345     Document Type: Article

References (37)

1. Mulatero P, Monticone S, Rainey WE, Veglio F, Williams TA. Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol. 2013; 9: 104-112.
2. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005; 45: 1243-1248.
3. Mulatero P, Monticone S, Bertello C, et al. Long-term cardio-and cerebro-vascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013; 98: 4826-4833.
4. Mulatero P, Milan A, Williams TA, Veglio F. Mineralocorticoid receptor blockade in the protection of target organ damage. Cardiovasc Hematol Agents Med Chem. 2006; 4: 75-91.
5. Fallo F, Pilon C, Urbanet R. Primary aldosteronism and metabolic syndrome. Horm Metab Res. 2012; 44: 208-214.
6. Funder JW, Carey RM, Fardella C, et al. The Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008; 93: 3266-3281.
7. Mulatero P, Bertello C, Rossato D, et al. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab. 2008; 93: 1366-1371.
8. Mulatero P, Bertello C, Sukor N, et al. Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension. 2010; 55: 667-673.
9. Monticone S, Satoh F, Giacchetti G, et al. Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. Hypertension. 2012; 59: 840-846.
10. Rossi GP, Barisa M, Allolio B, et al. The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2012; 97: 1606-1614.
11. Doppman JL, Gill JR Jr, Miller DL, et al. Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology. 1992; 184: 677-682.
12. Espiner EA, Ross DG, Yandle TG, Richards AM, Hunt PJ. Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab. 2003; 88: 3637-3644.
13. Ahmed AH, Cowley D, Wolley M, et al. Seated saline suppression testing for the diagnosis of primary aldosteronism-a preliminary study. J Clin Endocrinol Metab. 2014; 99(8): 2745-2753.
14. Kempers MJ, Lenders JW, van Outheusden L, et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009; 151: 329-337.
15. Monticone S, Viola A, Rossato D, et al. Adrenal vein sampling in primary aldosteronism: towards a standardised protocol [published online May 12, 2014]. Lancet Diabetes Endocrinol. doi: 10.1016/ S2213-8587(14)70069-5.
16. Rossi GP, Auchus RJ, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014; 63: 151-160.
17. Auchus RJ, Wians FH Jr, Anderson ME, et al. What we still do not know about adrenal vein sampling for primary aldosteronism. Horm Metab Res. 2010; 42: 411-415.
18. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004; 136: 1227-1235.
19. Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004; 89: 1045-1050.
20. Sawka AM, Young WF, Thompson GB, et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med. 2001; 135: 258-261.
21. Celen O, O'Brien MJ, Melby JC, Beazley RM. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg. 1996; 131: 646-650.
22. Giacchetti G, Ronconi V, Rilli S, Guerrieri M, Turchi F, Boscaro M. Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma. Eur J Endocrinol. 2009; 160: 639-646.
23. Nishikawa T, Omura M, Satoh F, et al. Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism-the Japan Endocrine Society 2009. Endocr J. 2011; 58: 711-721.
24. Vonend O, Ockenfels N, Gao X, et al. German Conn's Registry. Adrenal venous sampling: evaluation of the German Conn's registry. Hypertension. 2011; 57: 990-995.
25. Stowasser M, Gordon RD, Gunasekera TG, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens. 2003; 21: 2149-2157.
26. Rutherford JC, Taylor WL, Stowasser M, Gordon RD. Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production. World J Surg. 1998; 22: 1243-1245.
27. Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab. 2009; 94: 2437-2445.
28. Tu W, Eckert GJ, Hannon TS, et al. Racial differences in sensitivity of blood pressure to aldosterone. Hypertension. 63: 1212-1218.
29. Funder JW. Sensitivity to aldosterone: plasma levels are not the full story. Hypertension. 2014; 63: 1168-1170.
30. Fischer E, Hanslik G, Pallauf A, et al. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. J Clin Endocrinol Metab. 2012; 97: 3965-3973.
31. Nishimoto K, Nakagawa K, Li D, et al. Adrenocortical zonation inhumans under normal and pathological conditions. J Clin Endocrinol Metab. 2010; 95: 2296-2305.
32. Romero DG, Yanes LL, de Rodriguez AF, et al. Disabled-2 is expressed in adrenal zona glomerulosa and is involved in aldosterone secretion. Endocrinology. 2007; 148: 2644-2652.
33. Gomez-Sanchez CE, Rossi GP, Fallo F, Mannelli M. Progress in primary aldosteronism: present challenges and perspectives. Horm Metab Res. 2010; 42: 374-381.
34. Williams TA, Monticone S, Schack VR, et al. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension. 2014; 63: 188-195.
35. Scholl UI, Goh G, Stölting G, et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet. 2013; 45: 1050-1054.
36. Gomez-Sanchez CE, Gomez-Sanchez EP. Mutations of the potassium channel KCNJ5 causing aldosterone-producing adenomas: one or two hits? Hypertension. 2012; 59: 196-197.
37. Fernandes-Rosa FL, Williams TA, Riester A, et al. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension. 2014; 64: 354-361.